N.S.

BIO-TEC
ALBUMIN (BCG)
Colorimetric determination of serum albumin

INTENDED USE REAGENTS

NS Biotech albumin reagent is intended for the in vitro quantitative
determination of albumin in serum or plasma on both automated and manual
systems. R1 Albumin standard 4.0 g/dl

CLINICAL SIGNIFICANCE Succinate buffer,

R2 pH 4.2 75.0 mmol/l
Albumin is a carbohydrate-free protein, representing 55 – 65% of the total Bromcresol green 0.26 mmol/l
plasma proteins. It is synthesized in the liver and is noted for its ability of
configuration changes. It maintains the plasma colloidal osmotic pressure,
• Reagent Preparation & Stability
transports and stores a wide variety of ligands and serves as a source of
endogenous amino acids. Albumin binds and solubilizes a variety of All reagents are ready for use and stable up to the expiry date given
0
compounds amongst which are bilirubin, calcium, and long-chain fatty on label when stored at 2 – 8 C.
acids. Albumin also binds toxic heavy metal ions and many drugs, which is
why a decrease in albumin in the blood can have important pharmacokinetic SPECIMEN
2
consequences . Hyperalbuminemia is of little diagnostic significance except Serum or plasma*
in dehydration. Hypoalbuminemia is very common in many diseases and * The only accepted anticoagulants are heparin and EDTA.
stems from various factors: impaired synthesis, either primary as a result of
liver disease or secondary due to diminished protein intake; increased Specimen Preparation & Stability
catabolism because of tissue damage (severe burns) or inflammation;
malabsorption of amino acids (Crohn’s disease); proteinuria due to Patients should be following their usual diet and be in their usual
nephrotic syndrome; protein loss by way of feces (neoplastic disease). In state of health. Serum should be separated immediately from the
severe hypoalbuminemia plasma albumin levels are below 2.5 g/dl. The low clot. Analyze specimen promptly or store for less than 3 days at
0
plasma oncotic pressure allows water to move out of the blood capillaries 4 C. Albumin in the specimen remains stable for 6 months when
0 0 9
into the tissues (edema). Albumin measurements also allow monitoring of frozen at –20 C or indefinitely at -70 C .
the patient’s response to nutritional support and are a useful test of liver
3
function . PROCEDURE
ASSAY PRINCIPLE • Manual Procedure

For a number of years the standard method for albumin determination was Wavelength 580 - 630 nm
measurement of protein remaining in solution following salt precipitation of Cuvette 1 cm light path
0
4
globulin fractions . Electrophoresis has also been widely used. Temperature 20 - 25 C
Measurement of albumin has been greatly simplified by the introduction of Zero adjustment against reagent blank
5, 6
dye binding methods . The method using bromcresol green (BCG) is
7 Specimen Serum or plasma
more specific, sensitive, and less prone to pigment interference than the
earlier dye binding methods, and has been improved by reduction of the
reaction pH. Blank Standard Specimen

Albumin at pH 4.2 is sufficiently cationic to bind the anionic dye bromcresol

green (BCG) to form a blue-green colored complex. R2 2.5 ml 2.5 ml 2.5 ml

Albumin + BCG pH 4.2 Albumin-BCG complex Standard …… 10µl ……

The intensity of the blue-green color is directly proportional to albumin Specimen …… …… 10 µl

concentration in the specimen. It is determined by measuring the increase
in absorbance at 580 - 630 nm.
Mix, and Incubate for 5 minutes at room temperature Measure the
EXPECTED VALUES
absorbance of specimen (Aspecimen) and standard (Astandard) against
reagent blank.
8
Adults
The color is stable for 30 minutes.
18 – 60 years 3.5 – 5.0 g/dl
> 60 years 3.4 – 4.8 g/dl • Automated Procedure
User defined parameters for different auto analyzers are available
upon request.
Children
14 – 18 years 3.2 – 4.5 g/dl CALCULATION
4 days - 14 years 3.8 – 5.4 g/dl Calculate the albumin concentration in serum by using the following
formulae:
Newborns
Serum albumin Concentration=
< 4 days 2.8 – 4.4 g/dl
Absorbance of Specimen
X Standard value
Each laboratory should investigate the transferability of the expected Absorbance of Standard
values to its own patient population and if necessary determine its own
reference range. For diagnostic purposes, the albumin results should
• Unit conversion
always be assessed in conjunction with the patient’s medical history,
clinical examination, and other findings. g/dl x 1.45 = µmol/l

Expression of results in µmol/l is only used for binding albumin.

LINEARITY BIBLIOGRAPHY
When run as recommended, the assay is linear up to 7.0 g/dl. 1. Doumas, BT, Watson, WA & Biggs, HG (1971): Albumin standards and
the measurement of serum albumin with bromcresol green. Clin Chim
If result exceeds 7.0 mg/dl, specimen should be diluted with 0.9% NaCl
Acta. 31:87-96.
solution and reassayed. Multiply the result by the dilution factor.
2. Grant, GH, Silverman, LM, Christenson, RH (1987): Amino acids and
proteins. In: Fundamentals of Clinical Chemistry. 3rd ed. Philadelphia: WB
SENSTIVITY Saunders; 291-345.
The sensitivity is defined as the change of analytical response per unit 3. Marshall WJ, ed. (1989): Illustrated Textbook of Clinical Chemistry.
change in analyte concentration at a pathlength of 1 cm. London: Gower Medical Publishing; 207-218.
When run as recommended the sensitivity of this assay is 0.2 g/dl. 4. Reinhold, JG (1953): Standard Methods of Clinical Chemistry, (M.
Reiner, ed) p.88, Academic Press, New York.
QUALITY CONTROL 5. Bracken, JS and Klotz, IM (1953): Am. J. Clin. Pathol. 23: 1055.

It is recommended that controls (normal and abnormal) be included in: 6. Rutstein, DD, Ingenito, EF & Reynolds, WE (1954): J. Clin. Invest.
33:211.
• Each set of assays, or 7. Rodkey, FL (1964): Clin. Chem. 10:606.
• At least once a shift, or 8. Tietz, NW, ed (1990): Clinical Guide to laboratory Tests. 2nd ed.
Philadelphia: WB Saunders; 26-29.
• When a new bottle of reagent is used, or
9. Young, DS (1990): Effects of Drugs on Clinical Laboratory Tests. Third
• After preventive maintenance is performed or a clinical component Edition. 1990: 3: 6-12.
is replaced.
Commercially available control material with established albumin values
may be routinely used for quality control.
Failure to obtain the proper range of values in the assay of control
material may indicate:
• Reagent deterioration,
• Instrument malfunction, or
• Procedure errors.
The following corrective actions are recommended in such situations:
• Repeat the same controls.
• If repeated control results are outside the limits, prepare fresh
control serum and repeat the test.
• If results on fresh control material still remain outside the limits,
then repeat the test with fresh reagent.
• If results are still out of control, contact NS Biotec Technical
Services.

INTERFERING SUBSTANCES
• Anticoagulants:
Heparin and EDTA are the only accepted anticoagulants.
• Bilirubin:
No significant interference from free or conjugated bilirubin up to a
level of 60 mg/dl.
• Drugs:
9
Young in 1990 has published a comprehensive list of drugs and
substances, which may interfere with this assay.
• Haemoglobin:
Haemoglobin levels higher than 3.0 g/l increase the apparent
albumin concentration significantly.
• Lipemia:
Intralipid levels higher than 1.0 g/dl increase the apparent albumin
concentration significantly.

WARNING & PRECAUTIONS

• NS Biotec albumin reagent is for in vitro diagnostic use only.
Normal precautions exercised in handling laboratory reagents
should be followed.
• The reagents should be brought to room temperature before use.
• The reagent and sample volumes may be altered proportionally to
accommodate different spectrophotometer requirements.
• Valid results depend on an accurately calibrated instrument, timing,
and temperature control.
• Don’t use the reagent if it is turbid.

2 of 2